| Predicate |
Object |
| contentType |
Comparative Study|Journal Article|Research Support, Non-U.S. Gov't |
| endingPage |
91 |
| issn |
1573-739X
0928-1231 |
| issueIdentifier |
2 |
| pageRange |
83-91 |
| publicationName |
International Journal of Clinical Pharmacy |
| startingPage |
83 |
| bibliographicCitation |
Pen CL, Lilliu H. Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in? International Journal of Clinical Pharmacy. 2005 Apr;27(2):83–91. doi: 10.1007/s11096-004-2269-1. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4bb02be34638a69edef2665671f7cded
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_076b66ea1ef899ec3d71b2ddc46fd1cd |
| date |
200504 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/15999917
https://doi.org/10.1007/s11096-004-2269-1 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1573-739X
https://portal.issn.org/resource/ISSN/0928-1231
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2320 |
| language |
English |
| source |
https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Choice of GPIIb/IIIa antagonist in percutaneous coronary intervention: how should economic criteria be factored in? |
| discusses |
http://id.nlm.nih.gov/mesh/M0011126
http://id.nlm.nih.gov/mesh/M0016238
http://id.nlm.nih.gov/mesh/M0229697
http://id.nlm.nih.gov/mesh/M0211213
http://id.nlm.nih.gov/mesh/M0022203
http://id.nlm.nih.gov/mesh/M0001357
http://id.nlm.nih.gov/mesh/M0028424
http://id.nlm.nih.gov/mesh/M0227707 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID448812
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9b21d1a174c364b6f99c6662d34d6034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60947 |